333 related articles for article (PubMed ID: 19815816)
1. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Ambrose JA
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):75-9. PubMed ID: 19815816
[TBL] [Abstract][Full Text] [Related]
2. Acute cigarette smoke exposure reduces clot lysis--association between altered fibrin architecture and the response to t-PA.
Barua RS; Sy F; Srikanth S; Huang G; Javed U; Buhari C; Margosan D; Aftab W; Ambrose JA
Thromb Res; 2010 Nov; 126(5):426-30. PubMed ID: 20813396
[TBL] [Abstract][Full Text] [Related]
3. Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment.
Undas A; Kaczmarek P; Sladek K; Stepien E; Skucha W; Rzeszutko M; Gorkiewicz-Kot I; Tracz W
Thromb Haemost; 2009 Dec; 102(6):1176-82. PubMed ID: 19967149
[TBL] [Abstract][Full Text] [Related]
4. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia.
Lang T; Johanning K; Metzler H; Piepenbrock S; Solomon C; Rahe-Meyer N; Tanaka KA
Anesth Analg; 2009 Mar; 108(3):751-8. PubMed ID: 19224779
[TBL] [Abstract][Full Text] [Related]
5. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile.
Chakroun T; Gerotziafas GT; Seghatchian J; Samama MM; Hatmi M; Elalamy I
Thromb Haemost; 2006 May; 95(5):822-8. PubMed ID: 16676074
[TBL] [Abstract][Full Text] [Related]
6. The influence of poly-N-[(2,2-dimethyl-1,3-dioxolane)methyl]acrylamide on fibrin polymerization, cross-linking and clot structure.
Lai BF; Zou Y; Brooks DE; Kizhakkedathu JN
Biomaterials; 2010 Aug; 31(22):5749-58. PubMed ID: 20435346
[TBL] [Abstract][Full Text] [Related]
7. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
8. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
[TBL] [Abstract][Full Text] [Related]
9. Fibrin clot formation under diverse clotting conditions: Comparing turbidimetry and thromboelastography.
Zeng Z; Fagnon M; Nallan Chakravarthula T; Alves NJ
Thromb Res; 2020 Mar; 187():48-55. PubMed ID: 31954276
[TBL] [Abstract][Full Text] [Related]
10. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
11. Perioperative thromboelastography and sonoclot analysis in morbidly obese patients.
Pivalizza EG; Pivalizza PJ; Weavind LM
Can J Anaesth; 1997 Sep; 44(9):942-5. PubMed ID: 9305557
[TBL] [Abstract][Full Text] [Related]
12. Alteration of fibrin clot properties by ultrafine particulate matter.
Metassan S; Charlton AJ; Routledge MN; Scott DJ; Ariëns RA
Thromb Haemost; 2010 Jan; 103(1):103-13. PubMed ID: 20062921
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.
Kreutz RP; Owens J; Breall JA; Lu D; von der Lohe E; Bolad I; Sinha A; Flockhart DA
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):321-6. PubMed ID: 23429252
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and fibrin: scaffold proteins in hemostasis.
Lord ST
Curr Opin Hematol; 2007 May; 14(3):236-41. PubMed ID: 17414213
[TBL] [Abstract][Full Text] [Related]
15. Thromboelastographic phenotypes of fibrinogen and its variants: clinical and non-clinical implications.
Galanakis DK; Neerman-Arbez M; Brennan S; Rafailovich M; Hyder L; Travlou O; Papadakis E; Manco-Johnson MJ; Henschen A; Scharrer I
Thromb Res; 2014 Jun; 133(6):1115-23. PubMed ID: 24679643
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural comparison of the morphology of three different platelet and fibrin fiber preparations.
Pretorius E; Briedenhann S; Marx J; Smit E; Van Der Merwe C; Pieters M; Franz C
Anat Rec (Hoboken); 2007 Feb; 290(2):188-98. PubMed ID: 17441211
[TBL] [Abstract][Full Text] [Related]
17. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs.
Martini WZ; Cortez DS; Dubick MA; Park MS; Holcomb JB
J Trauma; 2008 Sep; 65(3):535-43. PubMed ID: 18784565
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopic evaluations of clot morphology during thrombelastography.
Kawasaki J; Katori N; Kodaka M; Miyao H; Tanaka KA
Anesth Analg; 2004 Nov; 99(5):1440-1444. PubMed ID: 15502045
[TBL] [Abstract][Full Text] [Related]
19. Perioperative thromboelastography analysis during suction-assisted lipectomy: a prospective cohort study.
Prado A; Andrades P; Danilla S; Parada F
J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):1453-8. PubMed ID: 18773874
[TBL] [Abstract][Full Text] [Related]
20. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
Nielsen VG
Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
